Olaparib: beside a new treatment under test
103 studies: a new drug, cell therapy or vaccine is what the study tests. Page 2 of 2. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Trial of Olaparib in Combination with AZD5363 (ComPAKT)CompletedNCT02338622Phase 1Report a problem
- Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsActive, not recruitingNCT02264678Phase 1Report a problem
- mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianActive, not recruitingNCT02208375Phase 1Report a problem